Virtus Investment Partners (NASDAQ:VRTS – Free Report) had its price target cut by Barclays from $239.00 to $221.00 in a research report released on Friday,Benzinga reports. They currently have an ...

Keurig Dr Pepper (NASDAQ:KDP – Free Report) had its price objective trimmed by Barclays from $39.00 to $36.00 in a research note issued to investors on Friday morning,Benzinga reports. The brokerage ...

In a report released on January 15, Nik Modi from RBC Capital maintained a Buy rating on The Estée Lauder Companies (EL – Research Report), ...

US stocks ended higher on Friday driven by gains in big tech and chip companies The Dow Jones Industrial Average rose 33470 points or 078 perce ...

Barclays analyst Andrew Lazar maintained a Buy rating on Mondelez International (MDLZ – Research Report) today and set a price target of ...

Marsh & McLennan Companies Inc (MMC) stock saw a decline, ending the day at $212.59 which represents a decrease of $-0.78 or -0.37% from the prior close of $213.37. The stock opened at $214.43 and ...

Fintel reports that on January 2, 2025, Piper Sandler downgraded their outlook ... With coverage of over 75,000 listed companies on all major stock exchanges, Fintel has the most comprehensive ...

Piper Sandler downgraded Biogen (NASDAQ ... ESALF), slashed its sales outlook for the companies' Alzheimer's therapy, Leqembi (lecanemab), in November. The Japanese drugmaker projected ¥42.5bn ...

Investing.com -- Piper Sandler downgraded Biogen Inc (NASDAQ:BIIB) from “overweight” to “neutral,” given a challenging transition period for the biotech firm. The brokerage hacked the ...

Just weeks before the holiday season, Barclays terminated 15 New York-based bankers and traders, along with 35 other employees, without issuing their annual bonuses—a move that has sparked ...